The independent source for health policy research, polling, and news.
April 29, 2021
In this Axios column, Drew Altman explores whether the long struggle with rising health costs has caused the tide to turn in corporate leaders’ attitudes towards government involvement in controlling health spending and whether it is part of a larger shift in comfort with government action to solve problems.
Column Read PostApril 5, 2021
In this Axios column, Drew Altman examines why doctors and nurses are such critical messengers in the effort to build vaccine confidence.
Column Read PostMarch 31, 2021
In an op-ed for The Washington Post, Drew Altman spells out how COVID-19 vaccination can be simplified to ensure that the public’s rising confidence in the vaccine isn’t thwarted by frustrating and sometimes dysfunctional websites.
Op-Ed Read PostMarch 22, 2021
In this Axios column Drew Altman writes about the recent attention to Republican vaccine resisters. “Republicans and rural Americans are among the most resistant vaccine holdouts and some strategies are emerging to reach them.” But “far from all Republicans are resisters” and “the bigger and quicker payoff will come from prioritizing the more moveable group of ‘wait and see’ Americans.”
Column Read PostMarch 1, 2021
In this Axios column, Drew Altman paints a more optimistic picture of the prospects for getting to herd immunity as vaccine confidence grows, but underscores the urgency of building vaccine confidence in Black and Latino communities where barriers to access and good information are obstacles to getting vaccinated.
Column Read PostFebruary 19, 2021
In this article for The Lancet, KFF’s Jennifer Kates and Lindsey Dawson, and five co-authors provide an overview of the coverage and financing landscape for HIV treatment and prevention in the U.S., discuss how the Affordable Care Act has changed the domestic health care system, examine the major programs that…
Read Post